title: Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.
abstract: Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system in which anti-aquaporin-4 (AQP4) autoantibodies (AQP4-IgG) cause damage to astrocytes by complement-dependent cytotoxicity (CDC). Various approaches have been attempted to produce NMO lesions in rodents, some involving genetically modified mice with altered immune cell function. Here, we found that mouse serum strongly inhibits complement from multiple species, preventing AQP4-IgG-dependent CDC. Effects of mouse serum on complement activation were tested in CDC assays in which AQP4-expressing cells were incubated with AQP4-IgG and complement from different species. Biochemical assays and mass spectrometry were used to characterize complement inhibitor(s) in mouse serum. Sera from different strains of mice produced almost no AQP4-IgG-dependent CDC compared with human, rat and guinea pig sera. Remarkably, addition of mouse serum prevented AQP4-IgG-dependent CDC caused by human, rat or guinea pig serum, with 50% inhibition at <5% mouse serum. Hemolysis assays indicated that the inhibitor(s) in mouse serum target the classical and not the alternative complement pathway. We found that the complement inhibitor(s) in mouse serum were contained in a serum fraction purified with protein-A resin; however, the inhibitor was not IgG as determined using serum from IgG-deficient mice. Mass spectrometry on the protein A-purified fraction produced several inhibitor candidates. The low intrinsic complement activity of mouse serum and the presence of complement inhibitor(s) limit the utility of mouse models to study disorders, such as NMO, involving the classical complement pathway.
authors: Departments of Medicine and Physiology, University of California, San Francisco, CA 94143, USA.
authors: Julien
authors: J
authors: Ratelade
authors: Departments of Medicine and Physiology, University of California, San Francisco, CA 94143, USA. Electronic address: Alan.Verkman@ucsf.edu.
authors: A S
authors: AS
authors: Verkman
mesh_terms: D000818:Animals; D051401:Aquaporin 4 / Q000276:immunology; D001323:Autoantibodies / Q000097:blood; D016466:CHO Cells; D051056:Complement Inactivating Agents / Q000097:blood* / Q000276:immunology; D003171:Complement Pathway, Classical / Q000276:immunology*; D003412:Cricetulus; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009471:Neuromyelitis Optica / Q000097:blood / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D051401:Aquaporin 4; D001323:Autoantibodies; D051056:Complement Inactivating Agents; D007074:Immunoglobulin G
keywords: AQP4-IgG; Aquaporin-4; Complement-dependent cytotoxicity; Mouse models; NMO